Literature DB >> 11856170

Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic Escherichia coli.

Juan J Martinez1, Scott J Hultgren.   

Abstract

Bladder infections caused by uropathogenic Escherichia coli (UPEC) depends on the ability of E. coli to express type 1 pili. The adhesive component of the pilus, FimH, mediates the invasion of E. coli into the bladder epithelium, a mechanism that facilitates the survival and persistence of E. coli in the bladder. The invasion mechanism requires actin polymerization, focal adhesion kinase phosphorylation and PI 3-kinase activation as well as the formation of FAK/PI 3-kinase and downstream vinculin/alpha-actinin complexes. In this study, we report a role for Rho-GTPase family members, namely RhoA, Cdc42 and Rac1, in the invasion process. Internalization of type 1-piliated E. coli (fimH+) and FimH-coated micro-spheres was inhibited by compactin, a pan-Rho-GTPase inhibitor and dominant negative isoforms of Rac1 and Cdc42. Expression of active Rac1 induced an internalization of E. coli that was insensitive to wortmannin and genistein. Expression of constitutively active Cdc42 induced the formation of FAK/PI 3-kinase and vinculin/alpha-actinin complexes whereas active Rac1 induced only a vinculin/alpha-actinin complex. Taken together, these data suggest that FimH-mediated invasion is dependent on GTP-binding protein activity that involves Cdc42 and PI 3-kinase activation probably upstream of Rac1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11856170     DOI: 10.1046/j.1462-5822.2002.00166.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  61 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 2.  Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Authors:  Adam J Lewis; Amanda C Richards; Matthew A Mulvey
Journal:  Microbiol Spectr       Date:  2016-12

Review 3.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

4.  Role of Rac1 in Escherichia coli K1 invasion of human brain microvascular endothelial cells.

Authors:  Rajyalakshmi S Rudrabhatla; Suresh K Selvaraj; Nemani V Prasadarao
Journal:  Microbes Infect       Date:  2005-09-16       Impact factor: 2.700

Review 5.  Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells.

Authors:  P Goluszko; B Nowicki
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Characteristics of the phagocytic cup induced by uropathogenic Escherichia coli.

Authors:  Huaibin Wang; Feng-Xia Liang; Xiang-Peng Kong
Journal:  J Histochem Cytochem       Date:  2008-03-17       Impact factor: 2.479

7.  TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder.

Authors:  Jeongmin Song; Brian L Bishop; Guojie Li; Matthew J Duncan; Soman N Abraham
Journal:  Cell Host Microbe       Date:  2007-06-14       Impact factor: 21.023

8.  Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway.

Authors:  Bijaya K Dhakal; Matthew A Mulvey
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

Review 9.  Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection.

Authors:  Ana Flores-Mireles; Teri N Hreha; David A Hunstad
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

Review 10.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.